Skip to main content
S. 3174 116th Congress Senate

Reversing the Youth Tobacco Epidemic Act of 2020

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the sale and marketing of tobacco products, and for other purposes.

Introduced: January 9, 2020 See on congress.gov
Health Administrative law and regulatory proceduresChild healthCivil actions and liabilityCongressional oversight
More subjectsShow fewer subjects
Consumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug, alcohol, tobacco useFood and Drug Administration (FDA)Government information and archivesGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth promotion and preventive careMarketing and advertisingMental healthMinority healthRacial and ethnic relationsRetail and wholesale tradesState and local government operationsUser charges and fees
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 9, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 9, 2020
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action January 9, 2020

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

Reversing the Youth Tobacco Epidemic Act of 2019

This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens).

Among other requirements, the bill

  • requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking;
  • requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes;
  • prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems;
  • prohibits flavors other than tobacco in a tobacco product;
  • prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances;
  • increases the user fees that the FDA collects from manufacturers and importers;
  • directs the FDA to regulate products containing synthetic nicotine (not made or derived from tobacco);
  • establishes a demonstration grant program to develop strategies for smoking cessation in medically underserved communities;
  • increases civil penalties for certain violations of restrictions on the sale of tobacco products; and
  • requires the Government Accountability Office to study e-cigarettes.  
 Related & companion bills 2
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3174: Reversing the Youth Tobacco Epidemic Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-S-3174/
MLA
"S. 3174: Reversing the Youth Tobacco Epidemic Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3174/.
Bluebook (legal)
S. 3174, 116th Cong. (2026), https://openamerica.io/bill/116-S-3174/.
Markdown link
[S. 3174: Reversing the Youth Tobacco Epidemic Act of 2020](https://openamerica.io/bill/116-S-3174/)
Report a problem